Crossmark

Beyond clinical trials – The cost saving associated with dapagliflozin use in Portugal hospital clinical practice

Crossref DOI link: https://doi.org/10.1016/j.repc.2024.04.012

Published Print: 2024-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Brito, Dulce

Fonseca, Cândida

Franco, Fátima

Lopes, Vanessa

Gonçalves, Sara

Baptista, Rui

Sequeira, Joana

Marques, Irene

Rego, Rita

Pimenta, Joana

Silva-Cardoso, José

Lopes, Margarida

Almeida, Mário
Funding

Funding for this research was provided by:

AstraZeneca
License Information

Text and Data Mining valid from 2024-12-01

Text and Data Mining valid from 2024-12-01

Version of Record valid from 2024-07-24
More Information

This article is maintained by: Elsevier

Article Title: Beyond clinical trials – The cost saving associated with dapagliflozin use in Portugal hospital clinical practice

Journal Title: Revista Portuguesa de Cardiologia

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.repc.2024.04.012

Content Type: article

Copyright: © 2024 Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L.U.